Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. - Wikidata - wikimedia - TriplyDB

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

http://www.wikidata.org/entity/Q35214991

about

Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity Lentiviral vectors in gene therapy: their current status and future potential Generation of diverse neural cell types through direct conversion Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis Gene therapy for hemophilia Quantitative comparison of constitutive promoters in human ES cells Retinal degeneration progression changes lentiviral vector cell targeting in the retina Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.Molecular engineering of viral gene delivery vehicles A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro.Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing Puromycin-resistant lentiviral control shRNA vector, pLKO.1 induces unexpected cellular differentiation of P19 embryonic stem cells.Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria Immunization delivered by lentiviral vectors for cancer and infectious diseases.Alternative oxidase expression in the mouse enables bypassing cytochrome c oxidase blockade and limits mitochondrial ROS overproduction Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant.Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk The role of unintegrated DNA in HIV infection Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.Development of viral vectors for use in cardiovascular gene therapy.MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.Therapeutic Vaccine Strategies against Human Papillomavirus.Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors.Methods for gene transfer to the central nervous system.Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.Human macrophages support persistent transcription from unintegrated HIV-1 DNA.Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis.Gene therapy for the prevention of vein graft disease

P2860

Q24301625-63CE306C-7EB2-4B4A-B357-4E2FFA53BF05 Q24629462-8FFD5D60-6870-40AB-8FE2-C14019A956B6 Q26765258-84697AF5-00B9-4968-98E2-8702D6659894 Q27487498-DCEDEE4B-83A2-4096-A83F-971C39DF30A9 Q27490501-41DD9B5B-A22D-495B-927A-563FA81635B9 Q28081911-C257F8A5-58AD-4C35-A077-2F5BD306AB94 Q28475300-3D3E5FDE-E793-472D-BCC8-118AFFF8517D Q28741007-AAF7B52F-D53C-4182-BB5B-3E1F13065545 Q30422793-73054672-09EE-4649-AD05-7423504C5F3D Q32183405-1466C85E-40C2-44E6-A27F-C5D5F0148C9F Q33353795-9FFD3828-5D76-4589-82AA-988B44AFFBDA Q33481640-C999B727-AB85-4CA8-B3B3-BD16D8DECB48 Q33564383-A20003FC-9E50-471A-A7D3-5716D6658225 Q33637259-0FCEB196-7369-460B-A411-C3FA9F0DCEB0 Q33655722-3CDF8A49-6C8B-4B8E-B2AC-60C0E738ECB9 Q33772540-B44BA75D-E5E9-48F0-A7E9-BE99079A1A4E Q33794201-C079308F-55A4-44C4-A98B-5B81B6E0649A Q33881920-68F4DB76-546C-460B-86CF-9F9FDA0E56C1 Q33903286-FCDBE057-3BCD-4C7D-8BAB-6A1C3FCC7099 Q34206875-779B1051-D080-41CB-9D54-37715B4D8BBB Q34467839-A3A2165A-EF59-4C79-B93A-9C00A6CA687E Q34469817-685A1B11-0049-48F5-A6F1-F6012559CC1D Q34539879-272E676F-EC74-414A-8310-229628FAE703 Q34539934-BEC9D476-970F-4B36-A665-EDE05DCE7810 Q34621737-C46D7FA2-5244-44A7-AF77-29C8EA5D8743 Q34745316-843887EA-5F37-4902-9304-C6D29B27C7AB Q35038004-FFFB9090-D6A5-43AF-AC61-708770871F92 Q35143730-85950A2F-4540-4A16-A9D3-27EA7F826956 Q35192991-F33BB959-E5A2-4E05-AFBB-D464734723A8 Q35260617-16C5D35F-5B92-4993-93CA-01248CFE9622 Q35803106-142330C0-435B-49AF-8E42-B5BEDDA90BD4 Q35826752-7D605F09-DFA9-496F-90BB-7D38CEB7FF81 Q35878409-9804D71B-ED3F-4D54-A3D2-327257D84B58 Q35902332-31CB1E77-BA55-4A43-A94A-56690963D237 Q36055898-16E2CBBC-CA5F-4C4D-9195-9C32058759BC Q36194681-096ECB27-DC68-430E-8A5E-BFC541AA4C1B Q36469473-1B33662D-F8F0-48D9-8476-8CBB1D4BD3C5 Q36511684-75E60EA8-A01E-48A1-B929-F371EFB28534 Q36667599-799E8DEB-8A12-43C8-908A-4D4F83277EC8 Q36698258-CCB0B632-2600-4BB4-A06F-FA4105462101

P2860

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

http://www.wikidata.org/entity/Q35214991

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@ast

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@en

type

label

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@ast

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@en

prefLabel

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@ast

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@en

P1433

Q35214991-AEE0EFA5-FB7A-4B24-96AC-9D311C193DD1

P1476

Q35214991-2948F506-3D90-49BB-9447-0B8D5D81509C

P2093

Q35214991-055F20B2-04E5-4D1D-9D35-AFC28A40E63E

Q35214991-07DAEA7B-D218-486E-896C-004F9F1E802B

Q35214991-19FD5348-6057-4397-97A2-4455CF9503B8

Q35214991-1EE8755A-390A-4FAA-9362-03856AE7BF41

Q35214991-4CDE35CD-F2BC-421E-AFA9-BCBD03BA98D3

Q35214991-8D9F82C3-66DB-4027-985C-069CAE560CD9

Q35214991-C321243F-4A9C-4D2E-B875-29021CD6E69B

Q35214991-FD2D0788-6766-4C56-971A-C8A166A3020C

P2860

Q35214991-0EA7173D-052B-4883-8FC6-E8DB9618BCBA

Q35214991-18158275-BDDD-45DD-B076-74A5B5B9AF2D

Q35214991-28B2F8F0-F60F-4345-B964-83E918ED93D7

Q35214991-2B954AB7-5877-4F9D-AD51-26DBDA16C0B4

Q35214991-3BF33AC7-A3AF-495D-9537-EE42B47D89EB

Q35214991-45142AC5-F381-4651-9A37-60A6C44D7255

Q35214991-4B81EC6A-AB06-4668-B712-69A08A041C9E

Q35214991-4CFAF2ED-955A-4987-BBA4-E455CC203DB4

Q35214991-5046B210-0457-45F0-A995-5B7B128707B4

Q35214991-54B7D5A4-AA42-4DF6-A4DA-B7412057BE84

P304

Q35214991-37D30876-982E-4619-8C88-32B5C3AD2B9E

P31

Q35214991-52ED2380-2D41-42B6-AA96-674C6D313BEB

P356

Q35214991-41BC1F86-1B3C-4CAB-81AE-E18FA244C2A1

P407

Q35214991-EF988C5A-550A-4DD8-A432-736C239DB094

P433

Q35214991-B98B6307-4DF6-4932-9E05-1EB3C64B391C

P478

Q35214991-15B5C31A-774C-4C7A-9FDB-9FD71C62AE67

P577

Q35214991-0B3814DC-679B-4573-AF1C-96280A8DF5EB

P5875

Q35214991-D1990EEC-645E-4195-834F-253E9F3DA920

P698

Q35214991-5F4F8268-4631-4848-9BD4-D9D78FD50DB5

P932

Q35214991-583FDA0A-6F38-46B6-914B-35E6F9D9B8CF

P356

PNAS.0606197103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Lentiviral vectors with a defe ...... pression in vitro and in vivo.

@en

P2093

Caroline Petit

http://www.w3.org/2001/XMLSchema#string

Chamsy Sarkis

http://www.w3.org/2001/XMLSchema#string

Charline Ladroue

http://www.w3.org/2001/XMLSchema#string

Che Serguera

http://www.w3.org/2001/XMLSchema#string

Hamid Mammeri

http://www.w3.org/2001/XMLSchema#string

Jacques Mallet

http://www.w3.org/2001/XMLSchema#string

Martine Barkats

http://www.w3.org/2001/XMLSchema#string

Stéphanie Philippe

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 gene expression: lessons from provirus and non-integrated DNA

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

Transcription start regions in the human genome are favored targets for MLV integration

HIV-1 integration in the human genome favors active genes and local hotspots

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

Development of a self-inactivating lentivirus vector.

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Effective gene therapy with nonintegrating lentiviral vectors.

Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells

P304

17684-17689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0606197103

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6701035

http://www.w3.org/2001/XMLSchema#string

P698

17095605

http://www.w3.org/2001/XMLSchema#string

P932

1693807

http://www.w3.org/2001/XMLSchema#string